Crystal structure reveals conservation of amyloid-β conformation recognized by 3D6 following humanization to bapineuzumab

INTRODUCTION: Immunotherapy targeting amyloid-β peptide is under active clinical investigation for treatment of Alzheimer’s disease (AD). Among the hypotheses being investigated for impact on clinical outcome are the preferred epitope or conformation of amyloid-β to target for treatment, and the mec...

Descripción completa

Detalles Bibliográficos
Autores principales: Feinberg, Hadar, Saldanha, José W, Diep, Linnea, Goel, Amita, Widom, Angela, Veldman, Geertruida M, Weis, William I, Schenk, Dale, Basi, Guriqbal S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095729/
https://www.ncbi.nlm.nih.gov/pubmed/25024748
http://dx.doi.org/10.1186/alzrt261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095729/
https://www.ncbi.nlm.nih.gov/pubmed/25024748
http://dx.doi.org/10.1186/alzrt261

Ejemplares similares